Health
SARS-CoV-2 evolves antibody resistance in immunocompromised patient – News-Medical.Net
Researchers in the United States who tracked the evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an immunocompromised patient found…
Researchers in the United States who tracked the evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an immunocompromised patient found that convalescent plasma therapy was associated with the emergence of viral variants that were less susceptible to neutralizing antibodies.
The SARS-CoV-2 virus is the agent responsible for the coronavirus 2019 (COVID-19) pandemic that continues to pose a significant threat to global public health and the worldwide economy.
The team’s analysis…
-
Noosa News21 hours agoTake a look behind the scenes at Noosa Arts Theatre
-
Noosa News21 hours agoWelcome for Greens homeless plan
-
General23 hours agoTexas opens probe into Kellogg’s health claims, dyes
-
General19 hours agoWhy an Australian journalist is teaching meditation in America’s toughest jails